Mitogen-activated protein kinases (MAPKs) are key components of intracellular signal transduction pathways that relay extracellular signals to the cell nucleus to activate transcription of genes involved in inflammation, cell migration, cell-cycle control, and apoptosis (1). The MAPKs are induced by proinflammatory cytokines such as tumor necrosis factor ␣ (TNF␣), interleukin-1 (IL-1), and macrophage migration inhibitory factor (MIF), and by growth factors and mediators of cellular stress, and regulate the expression of multiple proinflammatory genes, matrix metalloproteinases, and adhesion molecules (1,2). MAPK activation requires a 3-tiered cascade of protein phosphorylation, resulting in dual phosphorylation at conserved tyrosine and threonine residues. Although activation of the MAPK pathway is well described, less is known about endogenous negative regulators of MAPK, the MAPK